Cargando…

Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer

OBJECTIVE: To investigate the prognostic relevance of specific measurement parameters such as tumor diameter, tumor volume, tumor volume reduction rate (TVRR), and changes in the squamous cell carcinoma antigen (SCC-Ag) level in patients with locally-advanced cervical cancer (LACC) undergoing concur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wenjuan, Xiu, Siyi, Xie, Xingyun, Guo, Huiming, Xu, Yuanji, Bai, Penggang, Xia, Xiaoyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751300/
https://www.ncbi.nlm.nih.gov/pubmed/35012582
http://dx.doi.org/10.1186/s13014-021-01978-0
_version_ 1784631650673491968
author Chen, Wenjuan
Xiu, Siyi
Xie, Xingyun
Guo, Huiming
Xu, Yuanji
Bai, Penggang
Xia, Xiaoyi
author_facet Chen, Wenjuan
Xiu, Siyi
Xie, Xingyun
Guo, Huiming
Xu, Yuanji
Bai, Penggang
Xia, Xiaoyi
author_sort Chen, Wenjuan
collection PubMed
description OBJECTIVE: To investigate the prognostic relevance of specific measurement parameters such as tumor diameter, tumor volume, tumor volume reduction rate (TVRR), and changes in the squamous cell carcinoma antigen (SCC-Ag) level in patients with locally-advanced cervical cancer (LACC) undergoing concurrent radiotherapy and chemotherapy. METHODS: This was a retrospective study of 203 patients with stage IIA–IVA cervical squamous cell carcinoma who were newly diagnosed at our hospital between January 2011 and March 2015. Clinical data and pre-and post-treatment imaging information were collected and each parameter was calculated using 3DSlicer software. The pre/post-treatment tumor diameter (TD(pre/post)), tumor volume (TV(pre/post)), SCC-Ag (SCC(pre/post)), and TVRR, SCC-Ag reduction rate (SCCRR) were analyzed and their prognostic relevance evaluated. RESULTS: The median follow-up was 69 months. The 5-year overall survival (OS) and disease progression-free survival (PFS) rates were 69.5% and 64.5%, respectively. On univariate analysis, TD(pre/post), TV(pre/post), TVRR, SCC(pre/post) and SCCRR showed significant association with OS and PFS (P < 0.05). On multivariate analysis, TD(pre) [Hazard ratio (HR) = 0.373, P = 0.028], TD(post) (HR = 0.376, P = 0.003) and SCC(post) (HR = 0.374, P = 0.001) were independent predictors of OS. TVRR (HR = 2.998, P < 0.001), SCC(pre) (HR = 0.563, P = 0.041), and SCC(post) (HR = 0.253, P < 0.001) were independent predictors of PFS. Tumor measurement parameters showed a positive correlation with SCC-Ag (P < 0.05). CONCLUSION: TD(pre/post), TV(pre/post), TVRR, SCC(pre/post), and SCCRR were prognostic factors in LACC. TD(pre/post) and SCC(post) showed the most significant prognostic value. TVRR and SCC(pre/post) were closely related to disease progression. Further studies should investigate the correlation between measurement parameters of tumor and SCC-Ag.
format Online
Article
Text
id pubmed-8751300
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87513002022-01-12 Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer Chen, Wenjuan Xiu, Siyi Xie, Xingyun Guo, Huiming Xu, Yuanji Bai, Penggang Xia, Xiaoyi Radiat Oncol Research OBJECTIVE: To investigate the prognostic relevance of specific measurement parameters such as tumor diameter, tumor volume, tumor volume reduction rate (TVRR), and changes in the squamous cell carcinoma antigen (SCC-Ag) level in patients with locally-advanced cervical cancer (LACC) undergoing concurrent radiotherapy and chemotherapy. METHODS: This was a retrospective study of 203 patients with stage IIA–IVA cervical squamous cell carcinoma who were newly diagnosed at our hospital between January 2011 and March 2015. Clinical data and pre-and post-treatment imaging information were collected and each parameter was calculated using 3DSlicer software. The pre/post-treatment tumor diameter (TD(pre/post)), tumor volume (TV(pre/post)), SCC-Ag (SCC(pre/post)), and TVRR, SCC-Ag reduction rate (SCCRR) were analyzed and their prognostic relevance evaluated. RESULTS: The median follow-up was 69 months. The 5-year overall survival (OS) and disease progression-free survival (PFS) rates were 69.5% and 64.5%, respectively. On univariate analysis, TD(pre/post), TV(pre/post), TVRR, SCC(pre/post) and SCCRR showed significant association with OS and PFS (P < 0.05). On multivariate analysis, TD(pre) [Hazard ratio (HR) = 0.373, P = 0.028], TD(post) (HR = 0.376, P = 0.003) and SCC(post) (HR = 0.374, P = 0.001) were independent predictors of OS. TVRR (HR = 2.998, P < 0.001), SCC(pre) (HR = 0.563, P = 0.041), and SCC(post) (HR = 0.253, P < 0.001) were independent predictors of PFS. Tumor measurement parameters showed a positive correlation with SCC-Ag (P < 0.05). CONCLUSION: TD(pre/post), TV(pre/post), TVRR, SCC(pre/post), and SCCRR were prognostic factors in LACC. TD(pre/post) and SCC(post) showed the most significant prognostic value. TVRR and SCC(pre/post) were closely related to disease progression. Further studies should investigate the correlation between measurement parameters of tumor and SCC-Ag. BioMed Central 2022-01-10 /pmc/articles/PMC8751300/ /pubmed/35012582 http://dx.doi.org/10.1186/s13014-021-01978-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Wenjuan
Xiu, Siyi
Xie, Xingyun
Guo, Huiming
Xu, Yuanji
Bai, Penggang
Xia, Xiaoyi
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
title Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
title_full Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
title_fullStr Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
title_full_unstemmed Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
title_short Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
title_sort prognostic value of tumor measurement parameters and scc-ag changes in patients with locally-advanced cervical cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751300/
https://www.ncbi.nlm.nih.gov/pubmed/35012582
http://dx.doi.org/10.1186/s13014-021-01978-0
work_keys_str_mv AT chenwenjuan prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer
AT xiusiyi prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer
AT xiexingyun prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer
AT guohuiming prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer
AT xuyuanji prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer
AT baipenggang prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer
AT xiaxiaoyi prognosticvalueoftumormeasurementparametersandsccagchangesinpatientswithlocallyadvancedcervicalcancer